Health
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals Co., Ltd., today announced that it will present multiple posters at the American Academy of Neurology (AAN)Annual Meeting, taking place April 18–22, 2026, in Chicago, Illinois.
About this update from Sk Biopharmaceuticals Co., Ltd.
[{"type":"text","content":"Key Facts:","length":10,"tagName":"p"},{"type":"image","alt":"SK Life Science, Inc. (PRNewsfoto/SK Life Science, Inc.)","displaySize":"","headline":null,"caption":"SK Life Science, Inc. (PRNewsfoto/SK Life Science, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":143,"url":"https://media.zenfs.com/en/prnewswire.com/fcbc1cdab3d124f1865a5bb3593285c4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/G1JUbOJ4DOHrm9jz8CwYQg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI1Mg--/https://media.zenfs.com/en/prnewswire.com/fcbc1cdab3d124f1865a5bb3593285c4","width":400,"height":143}},"href":"https://mma.prnewswire.com/media/2565748/SK_Life_Science_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"list","items":[{"val":[{"type":"text","content":"SK Life Science, Inc. will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting (April 18–22, 2026, Chicago, Illinois)","length":148,"tagName":"p"}]},{"val":[{"type":"text","content":"Cenobamate data includes clinical outcomes, real-world evidence, pharmacokinetics and long-term efficacy","length":104,"tagName":"p"}]},{"val":[{"type":"text","content":"New analysis presented at AAN 2026 expands on survey findings first shared during National Epilepsy Awareness Month (November 2025)","length":131,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":383,"olType":false},{"type":"text","content":"PARAMUS, N.J., April 6, 2026 /PRNewswire/ -- SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals Co., Ltd., today announced that it will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting, taking place April 18–22, 2026, in Chicago, Illinois.","length":288,"tagName":"p"},{"type":"text","content":"The presentations highlight clinical and real-world evidence related to cenobamate, as well as new insights into the experiences and perspectives of people living with epilepsy and their healthcare providers.","length":208,"tagName":"p"},{"type":"text","content":"Among the presentations is a new methodological analysis from the "Hope, Hesitancy, and Hard Truths" survey, which explores how patients and providers communicate about epilepsy treatment and seizure control. Initial findings from the survey were shared during National Epilepsy Awareness Month in November 2025; the analysis p...